Geneva talks metabolism.
D045930:Anabolic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D004734:Energy Metabolism; D015444:Exercise / Q000502:physiology; D019247:HIV Wasting Syndrome / Q000209:etiology / Q000378:metabolism* / Q000628:therapy; D006801:Humans; D008060:Lipodystrophy / Q000209:etiology; D010074:Oxandrolone / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
D045930:Anabolic Agents; D000998:Antiviral Agents; D011480:Protease Inhibitors; D010074:Oxandrolone